Neuropsychopharmacology - Table of Contents alert Volume 43 Issue 8

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 43, Issue 8 In this issue Research Highlight Comment Research Highlight Review Article Article Also new AOP   Advertisement Have you visited the Neuropsychopharmacology Archival Perspectives page?  Highlighting the most cited articles from previous NPP issues. Recent additions include: - Abnormal fear conditioning and amygdala processing in an animal model of autism - Neural mechanisms of extinction learning and retrieval - Neurobiological similarities in depression and drug dependence Click here to access over 50 NPP articles from the past 5 years >>>    Research Highlight Clarifying punishment Kate M. Wassum Neuropsychopharmacology 2018 43 :1633 - 1634; April 13, 2018; 10.1038/s41386-018-0062-4   Abstract | Full Text Comment What a relief! A role for dopamine in positive (but not negative) valence Melissa J Sharpe Neuropsychopharmacology 2018 43 :1 - 2; February 27, 2018; 10.1038/s41386-018-0036-6   Abstract | Full Text Research Highlight Opportunities and needs in digital phenotyping Lisa A. Marsch Neuropsychopharmacology 2018 43 :1637 - 1638; April 03, 2018; 10.1038/s41386-018-0051-7   Abstract | Full Text Review Article Behavioral and neurobiological mechanisms of punishment: implications for psychiatric disorders Philip Jean-Richard-Dit-Bressel, Simon Killcross & Gavan P. McNally Neuropsychopharmacology 2018 43 :1639 - 1650; March 27, 2018; 10.1038/s41386-018-0047-3   Abstract | Full Text Article Role of the mesolimbic dopamine system in relief learning Dana Mayer, Evelyn Kahl, Taygun C. Uzuneser & Markus Fendt Neuropsychopharmacology 2018 43 :1651 - 1659; February 05, 2018; 10.1038/s41386-018-0020-1   Abstract | Full Text Relapse prediction in schizophrenia through digital phenotyping: a pilot study Ian Barnett, John Torous, Patrick Staples, Luis Sandoval, Matcheri Keshavan et al. Neuropsychopharmacology 2018 43 :1660 - 1666; February 22, 2018; 10.1038/s41386-018-0030-z   Abstract | Full Text Cell-subtype-specific changes in adenosine pathways in schizophrenia Sinead Marie O'Donovan, Courtney Sullivan, Rachael Koene, Emily Devine, Kathryn Hasselfeld et al. Neuropsychopharmacology 2018 43 :1667 - 1674; February 26, 2018; 10.1038/s41386-018-0028-6   Abstract | Full Text Influence of plasma cytokines on kynurenine and kynurenic acid in schizophrenia Joshua Chiappelli, Francesca M. Notarangelo, Ana Pocivavsek, Marian A. R. Thomas, Laura M. Rowland et al. Neuropsychopharmacology 2018 43 :1675 - 1680; February 27, 2018; 10.1038/s41386-018-0038-4   Abstract | Full Text Brain lactate and pH in schizophrenia and bipolar disorder: a systematic review of findings from magnetic resonance studies Asli Ercan Dogan, Cagri Yuksel, Fei Du, Virginie-Anne Chouinard & Dost Öngür Neuropsychopharmacology 2018 43 :1681 - 1690; March 14, 2018; 10.1038/s41386-018-0041-9   Abstract | Full Text Abnormal reward prediction-error signalling in antipsychotic naive individuals with first-episode psychosis or clinical risk for psychosis Anna O. Ermakova, Franziska Knolle, Azucena Justicia, Edward T. Bullmore, Peter B. Jones et al. Neuropsychopharmacology 2018 43 :1691 - 1699; April 05, 2018; 10.1038/s41386-018-0056-2   Abstract | Full Text Interaction between TSPO—a neuroimmune marker—and redox status in clinical high risk for psychosis: a PET–MRS study Sina Hafizi, Tania Da Silva, Jeffrey H. Meyer, Michael Kiang, Sylvain Houle et al. Neuropsychopharmacology 2018 43 :1700 - 1705; April 13, 2018; 10.1038/s41386-018-0061-5   Abstract | Full Text Salivary kynurenic acid response to psychological stress: inverse relationship to cortical glutamate in schizophrenia Joshua Chiappelli, Laura M. Rowland, Francesca M. Notarangelo, S. Andrea Wijtenburg, Marian A. R. Thomas et al. Neuropsychopharmacology 2018 43 :1706 - 1711; April 18, 2018; 10.1038/s41386-018-0072-2   Abstract | Full Text α7 Nicotinic receptor-modulating agents reverse the hyperdopaminergic tone in the MAM model of schizophrenia Gilda A Neves & Anthony A Grace Neuropsychopharmacology 2018 43 :1712 - 1720; April 19, 2018; 10.1038/s41386-018-0066-0   Abstract | Full Text Mice with reduced DAT levels recreate seasonal-induced switching between states in bipolar disorder Jared W. Young, Zackary A. Cope, Benedetto Romoli, Esther Schrurs, Aniek Joosen et al. Neuropsychopharmacology 2018 43 :1721 - 1731; February 27, 2018; 10.1038/s41386-018-0031-y   Abstract | Full Text Neural responses to cues paired with methamphetamine in healthy volunteers Kathryne Van Hedger, Sarah K. Keedy, Leah M. Mayo, Markus Heilig & Harriet de Wit Neuropsychopharmacology 2018 43 :1732 - 1737; January 30, 2018; 10.1038/s41386-017-0005-5   Abstract | Full Text Neural activation to monetary reward is associated with amphetamine reward sensitivity Natania A. Crane, Stephanie M. Gorka, Jessica Weafer, Scott A. Langenecker, Harriet de Wit et al. Neuropsychopharmacology 2018 43 :1738 - 1744; March 14, 2018; 10.1038/s41386-018-0042-8   Abstract | Full Text Cognitive deficit in methamphetamine users relative to childhood academic performance: link to cortical thickness Andy C. Dean, Angelica M. Morales, Gerhard Hellemann & Edythe D. London Neuropsychopharmacology 2018 43 :1745 - 1752; April 20, 2018; 10.1038/s41386-018-0065-1   Abstract | Full Text Amphetamine maintenance differentially modulates effects of cocaine, methylenedioxypyrovalerone (MDPV), and methamphetamine on intracranial self-stimulation and nucleus accumbens dopamine in rats Amy R. Johnson, Matthew L. Banks, Dana E. Selley & S. Stevens Negus Neuropsychopharmacology 2018 43 :1753 - 1762; April 19, 2018; 10.1038/s41386-018-0071-3   Abstract | Full Text M1-positive allosteric modulators lacking agonist activity provide the optimal profile for enhancing cognition Sean P. Moran, Jonathan W. Dickerson, Hyekyung P. Cho, Zixiu Xiang, James Maksymetz et al. Neuropsychopharmacology 2018 43 :1763 - 1771; March 14, 2018; 10.1038/s41386-018-0033-9   Abstract | Full Text A randomized, placebo-controlled trial of extended-release guanfacine in children with autism spectrum disorder and ADHD symptoms: an analysis of secondary outcome measures Laura C. Politte, Lawrence Scahill, Janet Figueroa, James T. McCracken, Bryan King et al. Neuropsychopharmacology 2018 43 :1772 - 1778; February 27, 2018; 10.1038/s41386-018-0039-3   Abstract | Full Text Histone deacetylase inhibitor MS-275 restores social and synaptic function in a Shank3-deficient mouse model of autism Kaijie Ma, Luye Qin, Emmanuel Matas, Lara J. Duffney, Aiyi Liu et al. Neuropsychopharmacology 2018 43 :1779 - 1788; April 19, 2018; 10.1038/s41386-018-0073-1   Abstract | Full Text Embryonic stem cell transplants as a therapeutic strategy in a rodent model of autism Jennifer J. Donegan, Angela M. Boley & Daniel J. Lodge Neuropsychopharmacology 2018 43 :1789 - 1798; February 07, 2018; 10.1038/s41386-018-0021-0   Abstract | Full Text Advertisement Nature Briefing is an essential round-up of science news, opinion and analysis, free in your inbox every weekday. With Nature Briefing, we'll keep you updated on the latest research, so you can focus on yours. Click here to sign up. Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Neuropsychopharmacology. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.